TY  - GEN
AU  - Daley-Yates,Peter T
AU  - Mehta,Rashmi
AU  - Chan,Robert H
AU  - Despa,Simona X
AU  - Louey,Margaret D
TI  - Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients
SN  - 1941-2703
PY  - 2015///0413
KW  - Administration, Inhalation
KW  - Adrenergic beta-2 Receptor Agonists
KW  - administration & dosage
KW  - Adult
KW  - Aerosols
KW  - Aged
KW  - Albuterol
KW  - Androstadienes
KW  - Area Under Curve
KW  - Asthma
KW  - diagnosis
KW  - Biological Availability
KW  - Bronchodilator Agents
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Drug Combinations
KW  - Dry Powder Inhalers
KW  - Equipment Design
KW  - Female
KW  - Fluticasone-Salmeterol Drug Combination
KW  - Humans
KW  - Lung
KW  - drug effects
KW  - Male
KW  - Middle Aged
KW  - New South Wales
KW  - New Zealand
KW  - Particle Size
KW  - Powders
KW  - Pulmonary Disease, Chronic Obstructive
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1089/jamp.2013.1040
ER  -